Compounds 1 and 3–5 exhibited promising concentration-dependent anti-proliferative effects in lung squamous cell carcinoma cells and lung adenocarcinoma cells, which correlated with co-expression of A2AR and PDE10A and increased cellular levels of cAMP. Here, ADORA2A is linked to squamous cell lung carcinoma.